Argenx just landed another Phase 3 win -- and Wall Street may be missing the bigger story The Motley Fool 1h
J&J’s Imaavy secures expanded US approval in rare blood disorder Pharmaceutical Technology 14h Johnson and Johnson
MHRA publishes regulatory roadmap for microbiome-based medicines amid growing AMR treatment interest Manufacturing Chemist 6d MHRA Pharma All sources
How gut bacteria linked to muscle strength could help fight ageing The Independent 5d Article paywall All sources
University College Cork's FemmeBiomehealth company spinning out in search of seed investment Echo Live 2d
